Martingale Asset Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $565K | Sell |
|
|||||
|
2025
Q1 | $230K | Sell |
|
|||||
|
2024
Q4 | $284K | Sell |
|
|||||
|
2024
Q3 | $244K | Hold |
|
|||||
|
2024
Q2 | $246K | Buy |
|
|||||
|
2024
Q1 | $385K | Buy |
|
|||||
|
2023
Q4 | $393K | Buy |
|
|||||
|
2023
Q3 | $271K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $235K | Hold |
|
|||||
|
2022
Q4 | $315K | Hold |
|
|||||
|
2022
Q3 | $559K | Buy |
|